- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05651984
Communication Strategies for Mechanically Ventilated Patients in Intensive Care Units
Comparative Analysis of Communication Board and Eye Tracking in Intensive Care Mechanically Ventilated Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Sample size:
The health professionals sample size is estimated by convenience to 100 professionals based on the accessible population in the study site (i.e., 95% of the health professionals from the study site). The patients sample size is estimated to 44 patients based on statistical calculation (with a type 1 error rate of 5%, a type 2 error rate of 10% and an allocation ratio of 1), including two groups of 22 patients.
Intervention:
The cross-sectional part involved the healthcare professionals through the "state of the art questionnaire" and the patients through the "ease of communication scale". The crossover part then randomized the patients from the cross-sectional part into two groups and the communication interfaces were divided into two time periods: group A received eye tracking/communication board sequence and group B received communication board/eye tracking sequence. For each period, the communication interfaces were evaluated through the "intervention form". The communication board provides simple messages based on orthographic and iconic content. The eye tracking computer-based system enables the production and construction of simple or complex messages (including word processing with spelling suggestions and voice synthesis), also based on orthographic and iconic content.
Statistical analysis:
The numerical data will be analyzed quantitatively using R software (version 2016 3.5.3). The Gaussian distribution will be estimated by mean/median comparison, histogram symmetry, quantile-quantile distribution and shapiro-wilk test. Statistical analysis of the crossover variables (treatment-period interaction, period effect, and treatment effect) will be performed using the Mann-Whitney (ordinal variables) and chi-square (binary variables) nonparametric tests. A p-value less than 0.05 was considered significant. The non-numerical data will be analyzed qualitatively by thematization and categorization.
Ethics approval and consent to participate:
The study protocol was approved by the Ethics Committee of the Hospital of Liège as Central Committee and the Hospital of Charleroi as Local Committee (number: B70720183767, reference: 2018/268). The information and consent documents intended for healthcare professionals and patients were validated by both Ethics Committees. Written informed consent was obtained from all participants (healthcare professionals and patient's legal representative) included in this study. All procedures performed through this study were in accordance with the 1964 Helsinki Declaration and its later amendments.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liège, Belgium, 4000
- University of Liege
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria - healthcare professionals:
- Working in the intensive care unit (study site).
Exclusion Criteria - healthcare professionals:
- Lack of consent.
Inclusion Criteria - patients:
- Being hospitalized in the intensive care unit (study site),
- Awake with a Richmond Agitation-Sedation Scale (RASS) between "restless" (+1) and "drowsy" (-1),
- Age of 18 years or older,
- French speaker.
Exclusion Criteria - patients:
- Lack of consent,
- Severe visual impairment (e.g., blindness).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Communication board
The communication board consists of a printed paper interface with a size of 42 x 30 cm.
|
The comparison between the communication board and eye tracking, conducted as a crossover, generates a randomization of the patients (from the cross-sectional part) into two groups and the communication interfaces were divided into two time periods: group A received eye tracking/communication board sequence and group B received communication board/eye tracking sequence.
|
|
Experimental: Eye tracking
The eye tracking device combines a laptop computer with a screen size of 29 x 16 cm, an eye tracker (PCEye Mini, Tobii dynavox, Danderyd, Sweden), an interface generated by a communication software (Communicator 5, Tobii dynavox) and a telescopic support.
|
The comparison between the communication board and eye tracking, conducted as a crossover, generates a randomization of the patients (from the cross-sectional part) into two groups and the communication interfaces were divided into two time periods: group A received eye tracking/communication board sequence and group B received communication board/eye tracking sequence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State of the art questionnaire - communication difficulties related to mechanical ventilation as experienced by healthcare professionals.
Time Frame: Before the use of communication interfaces.
|
Self-administered questionnaire assessing the difficulties to communicate with intubated or tracheostomized patients, the avoidance of interactions with patients, the perception of the help that could be provided by alternative communication systems and the interest in learning to use these systems.
|
Before the use of communication interfaces.
|
|
Ease of communication scale (ECS) - communication difficulties related to mechanical ventilation as experienced by patients.
Time Frame: Before the use of communication interfaces.
|
Multidimensional scale completed through an assisted interview and covering the difficulty to be understood; to communicate physical needs, thoughts, and feelings with notably relatives, nurses and physicians; and to ask questions about care and health status.
|
Before the use of communication interfaces.
|
|
Quantity of messages transmitted through the communication board.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Quantity of messages transmitted through the eye tracking.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Success rate for the communication board.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Success rate for the eye tracking.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Level of satisfaction for the communication board.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Level of satisfaction for the eye tracking.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Communication content for the communication board.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Communication content for the eye tracking.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Difficulties of use related to the communcation board.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
|
Difficulties of use related to the eye tracking.
Time Frame: During the use of communication interfaces.
|
Communication effectiveness indicator, collected through the intervention form.
|
During the use of communication interfaces.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Stephan Ehrmann, MD, PhD, University hospital and University of Tours
- Study Director: Laetitia Bodet-Contentin, MD, PhD, University hospital and University of Tours
- Principal Investigator: Yoann Marechal, MD, PhD, University hospital of Charleroi
- Principal Investigator: Emilie Szymkowicz, MSc, University of Liege
Publications and helpful links
General Publications
- Ten Hoorn S, Elbers PW, Girbes AR, Tuinman PR. Communicating with conscious and mechanically ventilated critically ill patients: a systematic review. Crit Care. 2016 Oct 19;20(1):333. doi: 10.1186/s13054-016-1483-2.
- Garry J, Casey K, Cole TK, Regensburg A, McElroy C, Schneider E, Efron D, Chi A. A pilot study of eye-tracking devices in intensive care. Surgery. 2016 Mar;159(3):938-44. doi: 10.1016/j.surg.2015.08.012. Epub 2015 Sep 8.
- Bodet-Contentin L, Gadrez P, Ehrmann S. Eye-tracking and speech-generating technology to improve communication with intubated intensive care unit patients: initial experience. Intensive Care Med. 2018 May;44(5):676-677. doi: 10.1007/s00134-018-5093-0. Epub 2018 Mar 3. No abstract available.
- Miglietta MA, Bochicchio G, Scalea TM. Computer-assisted communication for critically ill patients: a pilot study. J Trauma. 2004 Sep;57(3):488-93. doi: 10.1097/01.ta.0000141025.67192.d9.
- Maringelli F, Brienza N, Scorrano F, Grasso F, Gregoretti C. Gaze-controlled, computer-assisted communication in Intensive Care Unit: "speaking through the eyes". Minerva Anestesiol. 2013 Feb;79(2):165-75. Epub 2012 Nov 22.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- B707201837671
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.